DrugPatentWatch Database Preview

Janssen Prods Company Profile

JANSSEN PRODS has seven approved drugs.

There are thirty-three US patents protecting JANSSEN PRODS drugs.

There are nine hundred and eleven patent family members on JANSSEN PRODS drugs in sixty-six countries and one hundred and forty-three supplementary protection certificates in thirteen countries.

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-005	Dec 18, 2008		RX	Yes	No	8,597,876*PED	➤ Sign Up			Y	➤ Sign Up
Janssen Prods	OLYSIO	simeprevir sodium	CAPSULE;ORAL	205123-001	Nov 22, 2013		DISCN	Yes	No	9,353,103	➤ Sign Up				➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	SUSPENSION;ORAL	202895-001	Dec 16, 2011		RX	Yes	Yes	8,518,987*PED	➤ Sign Up			Y	➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-004	Dec 18, 2008		RX	Yes	No	8,597,876*PED	➤ Sign Up			Y	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-004	Dec 18, 2008	RE43596*PED	➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	SUSPENSION;ORAL	202895-001	Dec 16, 2011	RE43596*PED	➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-001	Jun 23, 2006	5,843,946*PED	➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-005	Dec 18, 2008	6,248,775*PED	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	800 mg	➤ Subscribe	2013-05-14

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
15/052	Ireland	➤ Sign Up	PRODUCT NAME: A COMBINATION OF RILPIVIRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF RILPIVIRINE, INCLUDING THE HYDROCHLORIDE SALT OF RILPIVIRINE, AND EMTRICITABINE; REGISTRATION NO/DATE: EU/1/11/737/001-002 20111128
854	Luxembourg	➤ Sign Up	PRODUCT NAME: COMBINAISON DE RILPIVIRINE OU UNE FORME THERAPEUTIQUE EQUIVALENTE QUI EN DERIVE TELLE QUE PROTEGEE PAR LE BREVET DE BASE, TEL QU'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE RILPIVIRINE, INCLUANT LE SEL CHLORHYDRATE DE RILPIVIRINE, ET TENOFOVIR, EN PARTICULIER LE FUMARATE DE TENOFOVIR DISOPROXIL
0859	Netherlands	➤ Sign Up	PRODUCT NAME: COBICISTAT, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN ATAZANAVIR, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER ATAZANAVIRSULFAAT; REGISTRATION NO/DATE: EU/1/15/1025 20150715
15/054	Ireland	➤ Sign Up	PRODUCT NAME: A COMBINATION OF RILPIVIRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING THE HYDROCHLORIDE SALT, AND TENOFOVIR, IN PARTICULAR TENOFOVIR DISOPROXIL FUMARATE; REGISTRATION NO/DATE: EU/1/11/737/001-002 20111128
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.